[1]
T. ALKA, “NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE”, Int J Pharm Pharm Sci, vol. 17, no. 2, pp. 1–15, Feb. 2025.